CHPA Response to NIH Review of Multivitamin/Mineral Supplement Use for Chronic Conditions

The following is a statement from the Consumer Healthcare Products Association in response to the National Institutes of Health State-of-the-Science Conference Panel Report on Multivitamin/Mineral Supplement Use for Chronic Disease Prevention held May 17 in Bethesda, M.D.:

Washington, D.C. (May 19, 2006)—Multivitamins and mineral supplements continue to play a prominent role in consumers’ healthcare regime, especially for those who lack sufficient intake of these important vitamins and minerals from their daily diets.

Earlier this week, a panel of health professionals was asked to explore multivitamin and mineral supplements’ efficacy in chronic disease prevention among the general adult population. While CHPA supports increased efforts to learn more about multivitamin and mineral use when treating chronic conditions, there are other key steps that must be taken in order to best serve consumers.

We feel it is important to implement mandatory adverse event reporting and to take steps to facilitate reporting. Adverse event reporting would strengthen U.S. Food and Drug Administration oversight over nutritional supplement safety, and ensure consumers have access to the most relevant information about the supplements they may be using.  In addition, CHPA continues to support full implementation and sufficient funding for the Dietary Supplement Health and Education Act of 1994, in addition to the release of uniform dietary supplement Good Manufacturing Practices (GMPs).

Millions of Americans turn to safe and health-promoting multivitamin and mineral supplements every day, and these steps will help them do so with renewed confidence.

Contacts: Elizabeth Assey and Virginia Cox, 202.429.9260


CHPA is the 125-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.